Avner, P. and E. Heard 2001. X-chromosome
inactivation: counting, choice and initiation. Nat Rev Genet. 2:59-67.
Stanford, W.L., J.B. Cohn and S.P. Cordes 2001. Gene-trap
mutagenesis: past, present and beyond. Nat Rev Genet. 2:756-768.
Lobe, C.G., K.E. Koop, W. Kreppner, et al. 1999. Z/AP, a double
reporter for cre-mediated recombination. Dev. Biology. 208:281-292.
Strachan, T. and A.P. Read 1999. Human Molecular Genetics. 576.
Silver, L.M. 1995. Mouse Genetics: Concepts and Applications. 362.
Crawley, J.N. 2000. What's Wrong With My Mouse. 329.
Collins, F.S. 1992. Postional cloning: Let's not call it reverse anymore. Nat. Genet. 1:3-6.
Zhang, Y., R. Proenca, M. Maffei, et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
Davies, K. 1994. Damage report for BRCA1. Nature. 372:574,
Futreal, P.A., Q. Liu, D. Shattuck-Eidens, et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 266:120-122,
Harshman, K., R. Bell, J. Rosenthal, et al. 1995. Comparison of the positional cloning methods used to isolate the BRCA1 gene. Hum Mol Genet. 4:1259-1266,
Kahn, P. 1996. Coming to grips with genes and risk. Science. 274:496-498,
Weber, B.L., K.J. Abel, L.C. Brody, et al. 1994. Familial breast cancer. Approaching the isolation of a susceptibility gene. Cancer. 74:1013-1020.
Hoffman, E.P., R.H. Brown, Jr. and L.M. Kunkel 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:919-928,
Koenig, M., E.P. Hoffman, C.J. Bertelson, et al. 1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 50:509-517,
Kunkel, L.M., A.P. Monaco, W. Middlesworth, et al. 1985. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A. 82:4778-4782,
Monaco, A.P., R.L. Neve, C. Colletti-Feener, et al. 1986. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature. 323:646-650,
Monaco, A.P., C.J. Bertelson, C. Colletti-Feener, et al. 1987. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet. 75:221-227.
Church, D.M., L.T. Banks, A.C. Rogers, et al. 1993. Identification of human chromosome 9 specific genes using exon amplification. Hum Mol Genet. 2:1915-1920,
Church, D.M., C.J. Stotler, J.L. Rutter, et al. 1994. Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat. Genet. 6:98-105.
Brown, P.O. and L. Hartwell 1998. Genomics and human disease--variations on variation. Nat. Genet. 18:91-93,
Collins, F.S., M.S. Guyer and A. Charkravarti 1997. Variations on a theme: cataloging human DNA sequence variation. Science. 278:1580-1581.
Richards, R.I. and G.R. Sutherland 1992. Dynamic mutations: a new class of mutations causing human disease. Cell. 70:709-712.
Fu, Y.H., D.P. Kuhl, A. Pizzuti, et al. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 67:1047-1058,
Jennings, C. 1995. How trinucleotide repeats may function. Nature. 378:127,
Kremer, E.J., M. Pritchard, M. Lynch, et al. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science. 252:1711-1714,
Mangiarini, L., K. Sathasivam, M. Seller, et al. 1996. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:493-506,
Mangiarini, L., K. Sathasivam, A. Mahal, et al. 1997. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat. Genet. 15:197-200.
Lin, X., C.J. Cummings and H.Y. Zoghbi 1999. Expanding our understanding of polyglutamine diseases through mouse models. Neuron. 24:499-502,
Ding, Q., J.J. Lewis, K.M. Strum, et al. 2002. Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J. Biol. Chem. 277:13935-13942.
Copeland, N.G. and N.A. Jenkins 1991. Development and applications of a molecular genetic linkage map of the mouse genome. Trends Genet. 7:113-118,
Copeland, N.G., N.A. Jenkins, D.J. Gilbert, et al. 1993. A genetic linkage map of the mouse: current applications and future prospects [see comments]. Science. 262:57-66,
Rowe, L.B., J.H. Nadeau, R. Turner, et al. 1994. Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm Genome. 5:253-274.
Makalowski, W., J. Zhang and M.S. Boguski 1996. Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. Genome Res. 6:846-857.
Lyon, M.F. 1993. Epigenetic inheritance in mammals. Trends Genet. 9:123-128.
Avner, P. and E. Heard 2001. X-chromosome inactivation: counting, choice and initiation. Nat Rev Genet. 2:59-67..
Brockdorff, N., A. Ashworth, G.F. Kay, et al. 1992. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell. 71:515-526,
Brown, C.J., B.D. Hendrich, J.L. Rupert, et al. 1992. The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell. 71:527-542,
Brown, C.J. and H.F. Willard 1994. The human X-inactivation centre is not required for maintenance of X- chromosome inactivation. Nature. 368:154-156,
Kay, G.F., G.D. Penny, D. Patel, et al. 1993. Expression of Xist during mouse development suggests a role in the initiation of X chromosome inactivation. Cell. 72:171-182,
Norris, D.P., D. Patel, G.F. Kay, et al. 1994. Evidence that random and imprinted Xist expression is controlled by preemptive methylation. Cell. 77:41-51,
Marahrens, Y., B. Panning, J. Dausman, et al. 1997. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes & Dev. 11:156-166,
Marahrens, Y., J. Loring and R. Jaenisch 1998. Role of the Xist gene in X chromosome choosing. Cell. 92:657-664.
Reik, W. and J. Walter 2001. Genomic imprinting: parental influence on the genome. Nat Rev Genet. 2:21-32.,
Reik, W. and J. Walter 2001. Evolution of imprinting mechanisms: the battle of the sexes begins in the zygote. Nat. Genet. 27:255-256..
Tilghman, S.M. 1999. The sins of the fathers and mothers: genomic imprinting in mammalian development. Cell. 96:185-193.
Clarke, H., S. Varmuza, V. Prideaux, et al. 1988. The developmental potential of parthenogenetically derived cells in chimeric mouse embryos: implications for action of imprinted genes. Development. 104:175-182,
Mann, J.R., I. Gadi, M.L. Harbison, et al. 1990. Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell. 62:251-260,
Thomson, J.A. and D. Solter 1988. The developmental fates of androgenetic, parthenogenetic and gynogenetic
cells in chimeric gastrulating mouse embryos. Genes & Dev. 2:1344-1351.
Brinster, R.l., H.Y. Chen, M.E. Trumbauer, et al. 1985. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA. 82:4438-4442,
Hanahan, D. 1989. Transgenic mice as probes into complex systems. Science. 246:1265-1274,
Hogan, B., R. Beddington, F. Costantini, et al. 1994. Manipulating the Mouse Embryo; A Laboratory Manual. 497,
Jaenisch, R. 1988. Transgenic Animals. Science. 240:1468-1474,
Koopman, P., J. Gubbay, N. Vivian, et al. 1991. Male development of chromosomally female mice transgenic for Sry [see comments]. Nature. 351:117-121.
Goldhamer, D.J., A. Faerman, M. Shani, et al. 1992. Regulatory elements that control the lineage-specific expression of myoD. Science. 256:538-542.
Bradley, A. and P. Liu 1996. Target practice in transgenics. Nat. Genet. 14:121-123,
Jasin, M., M.E. Moynahan and C. Richardson 1996. Targeted transgenesis. Proc Natl Acad Sci U S A. 93:8804-8808.
Hardouin, N. and A. Nagy 2000. Gene-trap-based target site for cre-mediated transgenic insertion. Genesis. 26:245-252..
Walters, M.C., S. Fiering, J. Eidemiller, et al. 1995. Enhancers increase the probability but not the level of gene expression. Proc. Natl. Acad. Sci. U.S.A.Proc Natl Acad Sci U S A. 92:7125-7129,
Walters, M.C., W. Magis, S. Fiering, et al. 1996. Transcriptional enhancers act in cis to suppress position-effect variegation. Genes & Dev. 10:185-195.
Friedrich, G. and P. Soriano 1991. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes & Dev. 5:1513-1523,
Gossler, A., A.L. Joyner, J. Rossant, et al. 1989. Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes. Science. 244:463-465,
Voss, A.K., T. Thomas and P. Gruss 1998. Efficiency assessment of the gene trap approach. Dev. Dynamics. 212:171-180.
Doetschman, T., R.G. Gregg, N. Maeda, et al. 1987. Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature. 330:576-578,
Doetschman, T., N. Maeda and O. Smithies 1988. Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 85:8583-8587,
Mansour, S.L., K.R. Thomas and M.R. Capecchi 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 336:348-352,
Thomas, K.R. and M.R. Capecchi 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:503-512.
Araki, K., M. Araki, J. Miyazaki, et al. 1995. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci U S A. 92:160-164,
Gu, H., J.D. Marth, P.C. Orban, et al. 1994. Deletion of a DNA polymerase ß gene segment in T cells using cell type-specific gene targeting. Science. 265:103-106.
Sauer, B. 1998. Inducible gene targeting in mice using the Cre/lox system. Methods. 14:381-392.
McHugh, T.J., K.I. Blum, J.Z. Tsien, et al. 1996. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell. 87:1339-1349,
Tsien, J.Z., D.F. Chen, D. Gerber, et al. 1996. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 87:1317-1326,
Tsien, J.Z., P.T. Huerta and S. Tonegawa 1996. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 87:1327-1338.
Barinaga, M. 1994. Knockout Mice: Round Two. Science. 265:26-28,
Gu, H. 1994. Gene targeting and its application to the study of B-cell development. Curr Opin Immunol. 6:308-312.
Fiering, S., C.G. Kim, E.M. Epner, et al. 1993. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region. Proc Natl Acad Sci U S A. 90:8469-8473,
Meyers, E.N., M. Lewandoski and G.R. Martin 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18:136-141.
St-Onge, L., P.A. Furth and P. Gruss 1996. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24:3875-3877.
Mills, A.A. 2001. Changing colors in mice: an inducible system that delivers. Genes & Dev. 15:1461-1467,
Cronin, C.A., W. Gluba and H. Scrable 2001. The lac operator-repressor system is functional in the mouse. Genes & Dev. 15:1506-1517.
Askew, G.R., T. Doetschman and J.B. Lingrel 1993. Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol. Cell. Biol. 13:4115-4124,
Detloff, P.J., J. Lewis, S.W. John, et al. 1994. Deletion and replacement of the mouse adult beta-globin genes by a "plug and socket" repeated targeting strategy. Mol. Cell. Biol. 14:6936-6943,
Lewis, J., B. Yang, P. Detloff, et al. 1996. Gene modification via "plug and socket" gene targeting. J Clin Invest. 97:3-5,
Valancius, V. and O. Smithies 1991. Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol. Cell. Biol. 11:1402-1408.
Lobe, C.G., K.E. Koop, W. Kreppner, et al. 1999. Z/AP, a double reporter for cre-mediated recombination. Dev. Biology. 208:281-292.,
Yamauchi, Y., K. Abe, A. Mantani, et al. 1999. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice. Dev. Biology. 212:191-203..
Guillemot, F., A. Nagy, A. Auerbach, et al. 1994. Essential role of Mash-2 in extraembryonic development. Nature. 371:333-336,
Guillemot, F., T. Caspary, S.M. Tilghman, et al. 1995. Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nat. Genet. 9:235-242.
Hanks, M., W. Wurst, L. Anson-Cartwright, et al. 1995. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science. 269:679-682.
Wang, Y., P.N.J. Schnegelsberg, J. Dausman, et al. 1996. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature. 379:823-825.
Ramirez-Solis, R., P. Liu and A. Bradley 1995. Chromosome engineering in mice. Nature. 378:720-724.
Brandon, E.P., R.L. Idzerda and G.S. McKnight 1995. Targeting the mouse genome: a compendium of knockouts (Part I). Curr Biol. 5:625-634,
Brandon, E.P., R.L. Idzerda and G.S. McKnight 1995. Targeting the mouse genome: a compendium of knockouts (Part III). Curr Biol. 5:873-881.
Nagy, A. and L. Mar 2001. Creation and use of a Cre recombinase transgenic database. Methods Mol Biol. 158:95-106..
Copp, A.J. 1995. Death before birth: clues from gene knockouts and mutations. Trends Genet. 11:87-93.
Betz, U.A.K., C.A.J. Voßhenrich, K. Rajewsky, et al. 1996. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination. Current Biology. 6:1307-1316,
Guillemot, F., et al. 1995. Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nat. Genet. 9:235-242.
Dietrich, S., F. Abou-Rebyeh, H. Brohmann, et al. 1999. The role of SF/HGF and c-Met in the development of skeletal muscle. Development. 126:1621-1629.,
Goto, Y. and N. Takagi 1998. Tetraploid embryos rescue embryonic lethality caused by an additional maternally inherited X chromosome in the mouse. Development. 125:3353-3363.,
Schorpp-Kistner, M., Z.Q. Wang, P. Angel, et al. 1999. JunB is essential for mammalian placentation. EMBO J. 18:934-948.,
Wang, Z.Q., F. Kiefer, P. Urbanek, et al. 1997. Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech Dev. 62:137-145..
Chen, J., R. Lansford, V. Stewart, et al. 1993. RAG-2-deficient blastocyst complementation: An assay of gene function in lymphocyte development. Proc. Natl. Acad. Sci. USA. 90:4528-4532,
Muthusamy, N., K. Barton and J.M. Leiden 1995. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 377:639-642.
Donehower, L.A., M. Harvey, H. Vogel, et al. 1995. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog. 14:16-22,
Harvey, M., M.J. McArthur, C.A. Montgomery, Jr., et al. 1993. Genetic background alters the spectrum of tumors that develop in p53- deficient mice. Faseb J. 7:938-943,
Sibilia, M. and E.F. Wagner 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:234-238.
Rozmahel, R., M. Wilschanski, A. Matin, et al. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat. Genet. 12:280-287.
Simpson, E.M., C.C. Linder, E.E. Sargent, et al. 1997. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 16:19-27.
Wakeland, E., L. Morel, K. Achey, et al. 1997. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today. 18:472-477.
Fiering, S., E. Epner, K. Robinson, et al. 1995. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes & Dev. 9:2203-2213.
Megeney, L.A., B. Kablar, K. Garrett, et al. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes & Dev. 10:1173-1183,
Rudnicki, M.A., T. Braun, S. Hinuma, et al. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene myf-5 and results in apparently normal muscle development. Cell. 71:383-390,
Rudnicki, M.A., P.N.J. Schnegelsberg, R.H. Stead, et al. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 75:1351-1359.
Hasty, P., A. Bradley, J.H. Morris, et al. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 364:501-506,
Nabeshima, Y., K. Hanaoka, M. Hayasaka, et al. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:532-535.
Braun, T. and H.H. Arnold 1995. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J. 14:1176-1186,
Tajbakhsh, S. and M.E. Buckingham 1994. Mouse limb muscle is determined in the absence of the earliest myogenic factor myf-5. Proc Natl Acad Sci U S A. 91:747-751,
Tajbakhsh, S., D. Rocancourt and M. Buckingham 1996. Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature. 384:266-270,
Tajbakhsh, S., E. Bober, C. Babinet, et al. 1996. Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev. Dynamics. 206:291-300.
Wang, Y., et al. 1996. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature. 379:823-825.
Olson, E.N., H.H. Arnold, P.W. Rigby, et al. 1996. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell. 85:1-4,
Yoon, J.K., E.N. Olson, H.H. Arnold, et al. 1997. Different MRF4 knockout alleles differentially disrupt Myf-5 expression: cis-regulatory interactions at the MRF4/Myf-5 locus. Dev. Biology. 188:349-362.
Doetschmann, T.C., H. Eistetter, M. Katz, et al. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islets and myocardium. J. Embryol. Exp. Morph. 87:27-45,
Schmitt, R.M., E. Bruyns and H.R. Snodgrass 1991. Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression. Genes & Dev. 5:728-740.
Keller, G., M. Kennedy, T. Papayannopoulou, et al. 1993. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13:473-486,
Keller, G.M. 1995. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol. 7:862-869.,
Wiles, M.V. and G. Keller 1991. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development. 111:259-267..
Shamblott, M.J., J. Axelman, S. Wang, et al. 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A. 95:13726-13731,
Solter, D. and J. Gearhart 1999. Putting stem cells to work. Science. 283:1468-1470,
Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, et al. 1998. Embryonic stem cell lines derived from human blastocysts. Science. 282:1145-1147.
Eggan, K., H. Akutsu, K. Hochedlinger, et al. 2000. X-Chromosome inactivation in cloned mouse embryos. Science. 290:1578-1581.,
Wilmut, I., A.E. Schnieke, J. McWhir, et al. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature. 385:810-813.
Rossant, J. 2002. A monoclonal mouse? Nature. 415:967-969,
Hochedlinger, K. and R. Jaenisch 2002. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature. 415:1035-1038,
Perry, A.C. and T. Wakayama 2002. Untimely ends and new beginnings in mouse cloning. Nat. Genet. 30:243-244,
Ogonuki, N., et al. 2002. Early death of mice cloned from somatic cells. Nat. Genet. 30:253-254.
Humpherys, D., et al. 2001. Epigenetic instability in ES cells and cloned mice. Science. 293:95-97.
Shin, T., D. Kraemer, J. Pryor, et al. 2002. A cat cloned by nuclear transplantation. Nature. 415:859,
Rideout, W.M., K. Hochedlinger, M. Kyba, et al. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell. 109:17-27,
Rideout, W.M., 3rd, K. Eggan and R. Jaenisch 2001. Nuclear cloning and epigenetic reprogramming of the genome. Science. 293:1093-1098,
Lanza, R.P., J.B. Cibelli, C. Blackwell, et al. 2000. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science. 288:665-669,
Humpherys, D., et al. 2001. Epigenetic instability in ES cells and cloned mice. Science. 293:95-97.
Jaenisch, R. and I. Wilmut 2001. Developmental biology. Don't clone humans! Science. 291:2552..
Rastan, S. and L.J. Beeley 1997. Functional genomics: going forwards from the databases. Curr. Opin. Genet. Dev. 7:777-783.